A detailed history of Israel Englander (Millennium Management LLC) transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Millennium Management LLC holds 5,394,691 shares of MREO stock, worth $19.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,394,691
Previous 3,201,705 68.49%
Holding current value
$19.3 Million
Previous $11.5 Million 92.37%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.45 - $4.87 $7.57 Million - $10.7 Million
2,192,986 Added 68.49%
5,394,691 $22.2 Million
Q2 2024

Aug 14, 2024

BUY
$2.58 - $4.25 $2.64 Million - $4.35 Million
1,022,570 Added 46.93%
3,201,705 $11.5 Million
Q1 2024

May 15, 2024

BUY
$2.3 - $4.05 $1.77 Million - $3.11 Million
768,818 Added 54.51%
2,179,135 $7.19 Million
Q4 2023

Feb 14, 2024

BUY
$1.19 - $2.42 $541,742 - $1.1 Million
455,246 Added 47.67%
1,410,317 $3.26 Million
Q2 2023

Aug 14, 2023

SELL
$0.79 - $1.43 $1.22 Million - $2.22 Million
-1,550,559 Reduced 61.88%
955,071 $1.26 Million
Q1 2023

May 15, 2023

BUY
$0.71 - $1.22 $847,939 - $1.46 Million
1,194,281 Added 91.07%
2,505,630 $1.77 Million
Q4 2022

Feb 14, 2023

BUY
$0.5 - $1.01 $28,869 - $58,315
57,738 Added 4.61%
1,311,349 $984,000
Q3 2022

Nov 14, 2022

BUY
$0.82 - $1.73 $452,406 - $954,466
551,715 Added 78.6%
1,253,611 $1.08 Million

Others Institutions Holding MREO

About Mereo Biopharma Group plc


  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $447M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.